Firms
Theme

CBAN

Colony Bankcorp Inc. · NYSE

News

5 latest

Zacks Investment Research

Colony Bankcorp (CBAN) Could Be a Great Choice

Colony Bankcorp (CBAN), a Finance stock headquartered in Fitzgerald, offers an attractive dividend yield of 2.37% with consistent dividend growth. The company has increased its dividend 5 times over the last 5 years with an average annual increase of 3.01%. With a Zacks Rank of #2 (Buy) and expected earnings growth of 11.73% for 2026, CBAN presents a compelling investment opportunity for income investors seeking both cash flow and capital appreciation.

Zacks Investment Research

Colony Bankcorp (CBAN) Earnings Expected to Grow: Should You Buy?

Colony Bankcorp (CBAN) is expected to report Q3 2026 earnings of $0.52 per share with 25.7% revenue growth, but an Earnings ESP of 0% and Zacks Rank #2 make it difficult to predict an earnings beat. Similarly, Renasant (RNST) is projected to post $0.94 EPS with a negative Earnings ESP of -1.06% and Zacks Rank #3, also making an earnings beat uncertain despite both companies' historical track records of beating estimates.

Zacks Investment Research

Colony Bankcorp (CBAN) Could Be a Great Choice

Colony Bankcorp (CBAN), a Southeast bank holding company, offers an attractive dividend yield of 2.35% with a $0.48 annualized dividend. The company has increased dividends 5 times over the last 5 years with an average annual increase of 3.01%. With a low payout ratio of 25% and expected earnings growth of 11.73% for 2026, CBAN presents a compelling investment opportunity for income investors, earning a Zacks Rank of #2 (Buy).

GlobeNewswire Inc.

Halper Sadeh LLC is Investigating Whether BZH, CBAN, ATKR, BGMS are Obtaining Fair Deals for their Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential securities law violations and breaches of fiduciary duties related to proposed mergers and acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be limiting superior competing offers. The investigations cover Beazer Homes' $33.50/share sale, Colony Bankcorp's merger, Atkore's $95.00/share sale, and Bio Green Med Solution's merger.

Mentions CBAN

Zacks Investment Research

Hilltop Holdings (HTH) Q3 Earnings and Revenues Miss Estimates

Hilltop Holdings reported Q3 2026 earnings of $0.44 per share, missing the consensus estimate of $0.64 and representing a 31.25% earnings surprise. Revenue also missed expectations at $309.51 million versus the estimate.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $CBAN · 0 threads

Sign in to post on $CBAN

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev